Chronic HBV carrierγs acceptance of regular surveilling programin china

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 2, 2013, Pages 288-292

  Fang, Qing ^a,b   Hao, You Hua ^a   Li, Lei ^a   Zhang, Zhen Hua ^a   Wang, Jun Zhong ^a   Chen, Ming Fa ^a   Kang, Jian ^a   Yang, Dong Liang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

Compliance; Follow up; Hepatitis B virus; Outpatient

Indexed keywords

ADULT; AGED; ARTICLE; CHINA; CHRONIC DISEASE; FEMALE; HEALTH SURVEY; HEPATITIS B; HETEROZYGOTE; HUMAN; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; PREVALENCE; STATISTICS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; CHINA; CHRONIC DISEASE; FEMALE; HEPATITIS B; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; PREVALENCE; YOUNG ADULT;

EID: 84902511955     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1113-z     Document Type: Article

References (25)

1. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med, 2004, 350(11):1118-1129
2. Liu J, Fan DM. Hepatitis B in China. Lancet, 2007, 369(9573):1582-1583
3. Liang XF, Chen YS, Wang XJ, et al. A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old: the report from Chinese Center for Disease Control and Prevention. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese), 2005, 26(9):655-658
4. Cui FQ, Wang XJ, Liang XF. Epidemiological analysis on reported hepatitis B under 15 years in China: the report from Chinese Center for Disease Control and Prevention. Zhongguo Yi miao He Mianyi Za Zhi (Chinese), 2006, 12 (3):206-208
5. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross sectional study of Asians in California. Hepatology, 2007, 46 (4):1034-1040
6. Wai CT, Mak B, Chua W, et al. The majority of hepatitis B carriers are not on regular surveillance in Singapore. Singapore Med J, 2004, 45(9):423-426
7. Lok AS. The maze of treatments for hepatitis B. N Engl J Med, 2005, 352(26):2743-2746
8. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med, 2005, 352(26):2673-2681
9. McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study. Hepatology, 2000, 32(4 Pt 1):842-846
10. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Zhongguo Bing Du Xue Za Zhi (Chinese), 2011, 1(1):9-22
11. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology, 2009, 50(3):661-662
12. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of Chronic Hepatitis B. J Hepatol, 2009, 50(2):227-242
13. Liaw YF, Leung N, Kao JH, et al. Asian-Pacific Consensus Statement on the Management of Chronic Hepatitis B: a 2008 Update. Hepatol Int, 2008, 2(3):263-283
14. Sherman M, Shafran S, Burak K, et al. CANADIAN CONSENSUS GUIDELINES Management of chronic hepatitis B: Consensus guidelines. Can J Gastroenterol, 2007, 21(Suppl C):5-24
15. Veldhuijzen IK, Toy M, Hahne SKM, et al. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology, 2006, 138(2): 522-530
16. Pawlotsky JM, Dusheiko G, Hatzakis A, et al. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: Recommendations for a standardized approach. Gastroenterology, 2008, 134(2):405-415
17. Giannini EG, Torre F, Basso M, et al. A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region- wide survey in Italy. J Clin Gastroenterol, 2009, 43(10):1001-1007
18. Jung CW, Tan J, Tan N, et al. Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population. J Gastroenterol Hepatol, 2010, 25(2):369-375
19. Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat, 2011, 18(6):377-383
20. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J (Engl), 2009, 122(1):3-4
21. Fang Q, Hao YH, Li L, et al. Primary construction of the electronic medical records for patients with liver diseases. Yi Xue Yu She Hui (Chinese), 2012, 25(4):29-31
22. Fang Q, Li L, Zhang ZH, et al. Analysis of the constituent ratio and its clinical diagnostic subtypes for patients with chronic HBsAg infection in their first outpatient visit. Nei Ke Ji Wei Zhong Zhen Yi Xue Za Zhi (Chinese), 2012, 18(2):98-101
23. Chao J, Chang ET, So SKS. Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. BMC Public Health, 2010, 10:98
24. Blumenthal D, Hsiao W. Privatization and its discontents? the evolving Chinese health care system. N Engl J Med, 2005, 353(11):1165-1170
25. Dong N, He B, Zhuang H. An online questionnaire survey on awareness of antiviral treatment in patients with chronic hepatitis B. Chin Hepatol, 2009, 14(1):8-10